Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)

导出原文传递

翻译打印收藏纠错

作者： Shapiro, Charles L. ^[1] ; Moriarty, James P. ^[2] ; Dusetzina, Stacie ^[3] ; Himelstein, Andrew L. ^[4] ; Foster, Jared C. ^[5] ; Grubbs, Stephen S. ^[6] ; Novotny, Paul J. ; Borah, Bijan J.

作者单位： Christiana Care NCI Community Oncol Res Program, Newark, DE USA ^[1] Mayo Clin, Canc Ctr, Rochester, MN USA ^[2] Univ North Carolina Chapel Hill, Chapel Hill, NC USA ^[3] Univ Michigan, Grand Rapids, MI USA ^[4] Helen F Graham Canc Ctr & Res Inst, Newark, DE USA ^[5] Icahn Sch Med Mt Sinai, One Gustave Levy Pl,Box 1079, New York, NY 10029 USA ^[6]

发布时间 2018-06-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Clinical Oncology

2017年35卷35期

3949-3955页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)

Journal of Clinical Oncology

相似文献

Journal of Clinical Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)

Journal of Clinical Oncology

相似文献

Journal of Clinical Oncology

相关期刊

检索历史清除